CAPOX + Bevacizumab + Tislelizumab Treating PD-L1 CPS < 5 Locally Advanced or Metastatic GEA

Clinical trial NCT05299476 · COMPLETED

Trial details

NCT number: NCT05299476
Sponsor: Chinese PLA General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastroesophageal Adenocarcinoma First-line Therapy PDL1 CPS < 5

Start date: 2022-04-25
Primary completion: 2025-01-20
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.